Donna M. Barten
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Cholinesterase and Neurodegenerative Diseases, Computational Drug Discovery Methods, Drug Transport and Resistance Mechanisms, Neuroscience and Neuropharmacology Research
Most-Cited Works
- → Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor(2010)184 cited
- → Hyperdynamic Microtubules, Cognitive Deficits, and Pathology Are Improved in Tau Transgenic Mice with Low Doses of the Microtubule-Stabilizing Agent BMS-241027(2012)171 cited
- → Dynamics of β-Amyloid Reductions in Brain, Cerebrospinal Fluid, and Plasma of β-Amyloid Precursor Protein Transgenic Mice Treated with a γ-Secretase Inhibitor(2005)159 cited
- → Passive Immunization with Phospho-Tau Antibodies Reduces Tau Pathology and Functional Deficits in Two Distinct Mouse Tauopathy Models(2015)148 cited
- → Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis(1994)131 cited
- → ??-Secretase Inhibitors for Alzheimer??s Disease(2006)128 cited
- → Therapeutic Strategies for Alzheimer’s Disease(2008)122 cited
- → Tau Overexpression Impacts a Neuroinflammation Gene Expression Network Perturbed in Alzheimer’s Disease(2014)107 cited
- → An Assessment of the Effects of Serotonin 6 (5-HT6) Receptor Antagonists in Rodent Models of Learning(2003)99 cited
- → Reductions in β-amyloid concentrations in vivo by the γ-secretase inhibitors BMS-289948 and BMS-299897(2005)93 cited